<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01101984</url>
  </required_header>
  <id_info>
    <org_study_id>08901</org_study_id>
    <nct_id>NCT01101984</nct_id>
  </id_info>
  <brief_title>Study of DE-089 Ophthalmic Solution in Patients With Dry Eye</brief_title>
  <official_title>A Randomized, Parallel- Group Comparison Study of DE-089 Ophthalmic Solution in Patients With Dry Eye (Comparison With 0.1% Sodium Hyaluronate Ophthalmic Solution) － A Multinational Study －</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Santen Pharmaceutical Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Santen Pharmaceutical Co., Ltd.</source>
  <brief_summary>
    <textblock>
      Safety and efficacy of DE-089 ophthalmic solution in patients with dry eye will be evaluated
      in comparison with sodium hyaluronate ophthalmic solution.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in the fluorescein and rose bengal staining score</measure>
    <time_frame>2 weeks and 4 weeks from baseline.</time_frame>
    <description>Changes in the fluorescein staining score at Week 4 / at the time of discontinuation (non-inferiority)
Changes in the rose bengal staining score at Week 4 / at the time of discontinuation (superiority)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in tear film breakup time (second)</measure>
    <time_frame>2 weeks and 4 weeks from baseline.</time_frame>
    <description>Changes in tear film breakup time (second) 2 weeks, 4 week after the study / at the discontinuation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Dry Eye</condition>
  <arm_group>
    <arm_group_label>DE-089</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DE-089 ophthalmic solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.1% sodium hyaluronate ophthalmic solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>diquafosol ophthalmic solution</intervention_name>
    <description>DE-089 topical ocular application, 6 times daily for 4 weeks.</description>
    <arm_group_label>DE-089</arm_group_label>
    <other_name>HA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.1% sodium hyaluronate ophthalmic solution.</intervention_name>
    <description>0.1% HA topical ocular application, 6 times daily for 4 weeks.</description>
    <arm_group_label>DE-089</arm_group_label>
    <arm_group_label>HA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Those who show:

               -  Keratoconjunctival disorder confirmed with vital dye staining

               -  Abnormal Schirmer score results

        Exclusion Criteria:

          -  Eye disease that needs therapy other than that for dry eye

          -  Those who need to wear contact lenses during the clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Eye &amp; Ear Hospital of Fudan University</name>
      <address>
        <city>Shanghai</city>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Singapore Eye Research Institute</name>
      <address>
        <city>Singapore</city>
        <zip>168751</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
    <country>Singapore</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2010</study_first_submitted>
  <study_first_submitted_qc>April 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2010</study_first_posted>
  <last_update_submitted>November 11, 2012</last_update_submitted>
  <last_update_submitted_qc>November 11, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 14, 2012</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Ophthalmic Solutions</mesh_term>
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

